FDA Inspection
Merz Pharma GmbH & Co., KGaAMerz Pharma GmbH & Co., KGaA – FDA Inspection, Mar 14, 2019
Record Details
This FDA Inspection record concerns Merz Pharma GmbH & Co., KGaA, with an inspection on March 14, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 1e9f4d3a-ae07-4492-817b-3e90a004f18c
Inspection Facts
- Inspection number
- 1088213
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Merz Pharma GmbH & Co., KGaA
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 29, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 4, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merz Pharma GmbH & Co., KGaA
- FDA Inspection 1250812 - 2022-06-29
- FDA Inspection 1021141 - 2017-07-04
- FDA Inspection 945417 - 2015-09-15
- FDA Inspection 853048 - 2013-09-25
- FDA Inspection 773481 - 2011-10-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.